Back to Journals » OncoTargets and Therapy » Volume 10

Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials

Total article views   HTML views PDF downloads Totals
12,773 Dovepress* 12,315+ 1,191 13,506
PubMed Central* 458 223 681
Totals 12,773 1,414 14,187
*Since 27 June 2017

View citations on PubMed Central and Google Scholar